APA

Bendell J. C., Joseph M., Barnes K., Mainwaring M., Shipley D., Reddy C., Blakely L., Blachly R., Lane C. M., Earwood C. & Kuzur M. (20170921). A Phase-2 Trial of Single Agent Axitinib as Maintenance Therapy Following First-Line Treatment With Modified FOLFOX/Bevacizumab in Patients With Metastatic Colorectal Cancer. : Cancer investigation.

Chicago

Bendell Johanna C, Joseph Mathew, Barnes Kirk, Mainwaring Mark, Shipley Dianna, Reddy Chandra, Blakely Laura, Blachly Ronald, Lane Cassie M, Earwood Chris and Kuzur Michel. 20170921. A Phase-2 Trial of Single Agent Axitinib as Maintenance Therapy Following First-Line Treatment With Modified FOLFOX/Bevacizumab in Patients With Metastatic Colorectal Cancer. : Cancer investigation.

Harvard

Bendell J. C., Joseph M., Barnes K., Mainwaring M., Shipley D., Reddy C., Blakely L., Blachly R., Lane C. M., Earwood C. and Kuzur M. (20170921). A Phase-2 Trial of Single Agent Axitinib as Maintenance Therapy Following First-Line Treatment With Modified FOLFOX/Bevacizumab in Patients With Metastatic Colorectal Cancer. : Cancer investigation.

MLA

Bendell Johanna C, Joseph Mathew, Barnes Kirk, Mainwaring Mark, Shipley Dianna, Reddy Chandra, Blakely Laura, Blachly Ronald, Lane Cassie M, Earwood Chris and Kuzur Michel. A Phase-2 Trial of Single Agent Axitinib as Maintenance Therapy Following First-Line Treatment With Modified FOLFOX/Bevacizumab in Patients With Metastatic Colorectal Cancer. : Cancer investigation. 20170921.